Negative Regulation of Tumor Suppressor p53 by MicroRNA miR-504

Molecular Cell

Volumn 38, Issue 5, 2010, Pages 689-699

  Hu, Wenwei ^a   Chan, Chang S ^b   Wu, Rui ^a   Zhang, Cen ^a   Sun, Yvonne ^a   Song, Jun S ^b   Tang, Laura H ^c   Levine, Arnold J ^a,b   Feng, Zhaohui ^a  

^a RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

^b INSTITUTE FOR ADVANCED STUDY   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

CELLCYCLE; DNA; RNA

Indexed keywords

MICRORNA; MICRORNA 504; PROTEIN P53; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BINDING SITE; CANCER CELL CULTURE; CARCINOGENICITY; CELL CYCLE ARREST; CELL STRAIN HCT116; CELL STRAIN MCF 7; CELL STRESS; CONTROLLED STUDY; FEMALE; GENETIC TRANSFECTION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IN VIVO STUDY; MOUSE; NONHUMAN; PROTEIN BINDING; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; SOLID TUMOR; WESTERN BLOTTING;

3' UNTRANSLATED REGIONS; ANIMALS; APOPTOSIS; BINDING SITES; CELL CYCLE; CELL LINE, TUMOR; CELL TRANSPLANTATION; FEMALE; GENE KNOCKDOWN TECHNIQUES; GENES, REPORTER; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; MICRORNAS; STRESS, PHYSIOLOGICAL; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53;

EID: 77953096272     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molcel.2010.05.027     Document Type: Article

References (45)

1. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116 (2004) 281-297
2. Bennett W.P., Hussain S.P., Vahakangas K.H., Khan M.A., Shields P.G., and Harris C.C. Molecular epidemiology of human cancer risk: gene-environment interactions and p53 mutation spectrum in human lung cancer. J. Pathol. 187 (1999) 8-18
3. Bentwich I., Avniel A., Karov Y., Aharonov R., Gilad S., Barad O., Barzilai A., Einat P., Einav U., Meiri E., et al. Identification of hundreds of conserved and nonconserved human microRNAs. Nat. Genet. 37 (2005) 766-770
4. Bommer G.T., Gerin I., Feng Y., Kaczorowski A.J., Kuick R., Love R.E., Zhai Y., Giordano T.J., Qin Z.S., Moore B.B., et al. p53-mediated activation of miRNA34 candidate tumor-suppressor genes. Curr. Biol. 17 (2007) 1298-1307
5. Bond G.L., Hu W., Bond E.E., Robins H., Lutzker S.G., Arva N.C., Bargonetti J., Bartel F., Taubert H., Wuerl P., et al. A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans. Cell 119 (2004) 591-602
6. Bunz F., Dutriaux A., Lengauer C., Waldman T., Zhou S., Brown J.P., Sedivy J.M., Kinzler K.W., and Vogelstein B. Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 282 (1998) 1497-1501
7. Buzzai M., Jones R.G., Amaravadi R.K., Lum J.J., DeBerardinis R.J., Zhao F., Viollet B., and Thompson C.B. Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth. Cancer Res. 67 (2007) 6745-6752
8. Caldas C., and Brenton J.D. Sizing up miRNAs as cancer genes. Nat. Med. 11 (2005) 712-714
9. Calin G.A., and Croce C.M. MicroRNA signatures in human cancers. Nat. Rev. Cancer 6 (2006) 857-866
10. Calin G.A., Sevignani C., Dumitru C.D., Hyslop T., Noch E., Yendamuri S., Shimizu M., Rattan S., Bullrich F., Negrini M., and Croce C.M. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc. Natl. Acad. Sci. USA 101 (2004) 2999-3004
11. Chen J., Wu X., Lin J., and Levine A.J. mdm-2 inhibits the G1 arrest and apoptosis functions of the p53 tumor suppressor protein. Mol. Cell. Biol. 16 (1996) 2445-2452
12. Cimmino A., Calin G.A., Fabbri M., Iorio M.V., Ferracin M., Shimizu M., Wojcik S.E., Aqeilan R.I., Zupo S., Dono M., et al. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc. Natl. Acad. Sci. USA 102 (2005) 13944-13949
13. Cummins J.M., He Y., Leary R.J., Pagliarini R., Diaz Jr. L.A., Sjoblom T., Barad O., Bentwich Z., Szafranska A.E., Labourier E., et al. The colorectal microRNAome. Proc. Natl. Acad. Sci. USA 103 (2006) 3687-3692
14. Deng C., Zhang P., Harper J.W., Elledge S.J., and Leder P. Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 82 (1995) 675-684
15. Feng Z., Hu W., de Stanchina E., Teresky A.K., Jin S., Lowe S., and Levine A.J. The regulation of AMPK beta1, TSC2, and PTEN expression by p53: stress, cell and tissue specificity, and the role of these gene products in modulating the IGF-1-AKT-mTOR pathways. Cancer Res. 67 (2007) 3043-3053
16. Feng Z., Hu W., Teresky A.K., Hernando E., Cordon-Cardo C., and Levine A.J. Declining p53 function in the aging process: a possible mechanism for the increased tumor incidence in older populations. Proc. Natl. Acad. Sci. USA 104 (2007) 16633-16638
17. Fukuda Y., Kurihara N., Imoto I., Yasui K., Yoshida M., Yanagihara K., Park J.G., Nakamura Y., and Inazawa J. CD44 is a potential target of amplification within the 11p13 amplicon detected in gastric cancer cell lines. Genes Chromosomes Cancer 29 (2000) 315-324
18. Griffiths-Jones S., Grocock R.J., van Dongen S., Bateman A., and Enright A.J. miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res. 34 Database issue (2006) D140-D144
19. Grimson A., Farh K.K., Johnston W.K., Garrett-Engele P., Lim L.P., and Bartel D.P. MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol. Cell 27 (2007) 91-105
20. He L., Thomson J.M., Hemann M.T., Hernando-Monge E., Mu D., Goodson S., Powers S., Cordon-Cardo C., Lowe S.W., Hannon G.J., and Hammond S.M. A microRNA polycistron as a potential human oncogene. Nature 435 (2005) 828-833
21. He L., He X., Lowe S.W., and Hannon G.J. microRNAs join the p53 network-another piece in the tumour-suppression puzzle. Nat. Rev. Cancer 7 (2007) 819-822
22. Higuchi R., Krummel B., and Saiki R.K. A general method of in vitro preparation and specific mutagenesis of DNA fragments: study of protein and DNA interactions. Nucleic Acids Res. 16 (1988) 7351-7367
23. Hu W., Feng Z., Ma L., Wagner J., Rice J.J., Stolovitzky G., and Levine A.J. A single nucleotide polymorphism in the MDM2 gene disrupts the oscillation of p53 and MDM2 levels in cells. Cancer Res. 67 (2007) 2757-2765
24. Hu W., Feng Z., Teresky A.K., and Levine A.J. p53 regulates maternal reproduction through LIF. Nature 450 (2007) 721-724
25. Kastan M.B., Zhan Q., el-Deiry W.S., Carrier F., Jacks T., Walsh W.V., Plunkett B.S., Vogelstein B., and Fornace Jr. A.J. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 71 (1992) 587-597
26. Kent O.A., and Mendell J.T. A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes. Oncogene 25 (2006) 6188-6196
27. Kloosterman W.P., and Plasterk R.H. The diverse functions of microRNAs in animal development and disease. Dev. Cell 11 (2006) 441-450
28. Le M.T., Teh C., Shyh-Chang N., Xie H., Zhou B., Korzh V., Lodish H.F., and Lim B. MicroRNA-125b is a novel negative regulator of p53. Genes Dev. 23 (2009) 862-876
29. Levine A.J., Hu W., and Feng Z. The P53 pathway: what questions remain to be explored?. Cell Death Differ. 13 (2006) 1027-1036
30. Lewis B.P., Burge C.B., and Bartel D.P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120 (2005) 15-20
31. Lilljebjörn H., Heidenblad M., Nilsson B., Lassen C., Horvat A., Heldrup J., Behrendtz M., Johansson B., Andersson A., and Fioretos T. Combined high-resolution array-based comparative genomic hybridization and expression profiling of ETV6/RUNX1-positive acute lymphoblastic leukemias reveal a high incidence of cryptic Xq duplications and identify several putative target genes within the commonly gained region. Leukemia 21 (2007) 2137-2144
32. Lim L.P., Lau N.C., Garrett-Engele P., Grimson A., Schelter J.M., Castle J., Bartel D.P., Linsley P.S., and Johnson J.M. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 433 (2005) 769-773
33. Lu J., Getz G., Miska E.A., Alvarez-Saavedra E., Lamb J., Peck D., Sweet-Cordero A., Ebert B.L., Mak R.H., Ferrando A.A., et al. MicroRNA expression profiles classify human cancers. Nature 435 (2005) 834-838
34. Meister G., and Tuschl T. Mechanisms of gene silencing by double-stranded RNA. Nature 431 (2004) 343-349
35. Michael M.Z., O' Connor S.M., van Holst Pellekaan N.G., Young G.P., and James R.J. Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol. Cancer Res. 1 (2003) 882-891
36. Moran D.M., Gawlak G., Jayaprakash M.S., Mayar S., and Maki C.G. Geldanamycin promotes premature mitotic entry and micronucleation in irradiated p53/p21 deficient colon carcinoma cells. Oncogene 27 (2008) 5567-5577
37. Murphy M.E. Polymorphic variants in the p53 pathway. Cell Death Differ. 13 (2006) 916-920
38. Nilsson B., Johansson M., Heyden A., Nelander S., and Fioretos T. An improved method for detecting and delineating genomic regions with altered gene expression in cancer. Genome Biol. 9 (2008) R13
39. Pillai R.S., Bhattacharyya S.N., and Filipowicz W. Repression of protein synthesis by miRNAs: how many mechanisms?. Trends Cell Biol. 17 (2007) 118-126
40. Plasterk R.H. Micro RNAs in animal development. Cell 124 (2006) 877-881
41. Raver-Shapira N., Marciano E., Meiri E., Spector Y., Rosenfeld N., Moskovits N., Bentwich Z., and Oren M. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol. Cell 26 (2007) 731-743
42. Renedo M., Martinez-Delgado B., Arranz E., Garcia M., Urioste M., Martinez-Ramirez A., Rivas C., Cigudosa J.C., and Benitez I. Chromosomal changes pattern and gene amplification in T cell non-Hodgkin's lymphomas. Leukemia 15 (2001) 1627-1632
43. Vogelstein B., Lane D., and Levine A.J. Surfing the p53 network. Nature 408 (2000) 307-310
44. Vousden K.H., and Prives C. Blinded by the light: the growing complexity of p53. Cell 137 (2009) 413-431
45. Yoon C.H., Lee E.S., Lim D.S., and Bae Y.S. PKR, a p53 target gene, plays a crucial role in the tumor-suppressor function of p53. Proc. Natl. Acad. Sci. USA 106 (2009) 7852-7857